Lonza sell "Inhalation Formulation Services"

Inhaled drug products for nasal or pulmonary delivery remain popular given the global prevalence of respiratory disease, and the lung's absorptive capacity continues to be studied as an attractive route for both local and systemic delivery. Particle engineering, one of Lonza's core strengths, is essential to achieving the particle size distribution needed for effective dry powder inhaler (DPI) formulation. DPI technology has become the preferred inhalation-formulation approach over other dry powder or aerosol technologies; lactose-blend or carrier-free DPI approaches require precise particle engineering through micronization/jet milling or spray drying respectively, and deep expertise across both particle size reduction and spray drying lets Lonza scientists select the most suitable technology for each DPI application.